Global STD Testing Kits Market Insights, Forecast to 2028

Market Analysis and Insights: Global STD Testing Kits Market
Due to the COVID-19 pandemic, the global STD Testing Kits market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Chlamydia Testing accounting for % of the STD Testing Kits global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China STD Testing Kits market size is valued at US$ million in 2021, while the US and Europe STD Testing Kits are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe STD Testing Kits landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of STD Testing Kits include Danaher Corporation, Affymetrix, BioMerieux, Cepheid Inc., Bio-Rad Laboratories, Alere Inc., DiaSorin, Orasure and F. Hoffmann-La Roche, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global STD Testing Kits Scope and Segment
STD Testing Kits market is segmented by Type and by Application. Players, stakeholders, and other participants in the global STD Testing Kits market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type
Chlamydia Testing
Gonorrhoea Testing
Hepatitis C Testing
HIV Testing
Syphilis Testing
Trichomonas’s Testing

Segment by Application
Hospitals
Homecare
Diagnostic Centres
Others

By Company
Danaher Corporation
Affymetrix
BioMerieux
Cepheid Inc.
Bio-Rad Laboratories
Alere Inc.
DiaSorin
Orasure
F. Hoffmann-La Roche
Abbott Laboratories
Becton Dickinson and Company
Hologic Inc.

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE